BlackThorn Therapeutics Overview
Contact top employees from
BlackThorn Therapeutics
Summary
BlackThorn Therapeutics is a private company that has been in the industry for 12 years. The company currently specializes in the Biotechnology, Medical Research & Laboratories, Pharmaceuticals areas. The position of the President & CEO is occupied by William J Martin. Its headquarters is located at San Francisco, California, USA. The number of employees ranges from 25 to 100. The annual revenue of BlackThorn Therapeutics varies between 100K and 5.0M. Total funding of the company - $138M. To connect with BlackThorn Therapeutics employee register on SignalHire.
BlackThorn Therapeutics industries
Biotechnology
Headquarters Location
BlackThorn Therapeutics Employees Size
10-50 employees
SIC Code
8731, 2834
DMA Code
San Francisco Bay Area
Founded
2015
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
BlackThorn Therapeutics Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2017 | Privately Held | 1 - 25 | 3M | $40M | |
| 2011 | Privately Held | 250 - 500 | 150M | $411.2M | |
| 2011 | Privately Held | 1 - 25 | < 1M | $10M | |
| 2013 | Public Company | 100 - 250 | 24.6M | $407.5M | |
| 2015 | Public Company | 250 - 500 | 357.1M | $597M | |
| 2013 | Privately Held | 25 - 100 | 8M | $94.3M | |
| 2001 | Privately Held | 25 - 100 | 7M | $208.4M | |
| 2012 | Public Company | 25 - 100 | < 1M | $308.1M | |
| 2015 | Privately Held | 25 - 100 | 6M | $36M | |
| 2015 | Privately Held | 25 - 100 | 26.2M | $223.2M | |
| 2014 | Privately Held | 25 - 100 | 6M | $103.8M | |
| 2000 | Privately Held | 25 - 100 | 6M | $222.9M | |
| 2014 | Privately Held | 25 - 100 | 8.5M | $291.6M | |
| 1878 | Public Company | 5.0K - 10K | 1.9B | $0 | |
| 2011 | - | 500-1000 | - | $- | |
| 2011 | - | 10-50 | - | $- | |
| - | - | 10-50 | - | $- | |
| - | - | 500-1000 | - | $- | |
| - | - | 1-10 | - | $- |
BlackThorn Therapeutics Funding
By Q2 2019, BlackThorn Therapeutics has participated in at least 4 funding rounds and has raised a minimum of 138.0M. Funding increased noticeable in Q2 2019 — by 68.0M compared to the previous Q2 2017. BlackThorn Therapeutics raised the least in Q2 2017 at 8.0M, while the most successful funding round in Q2 2019 raised 76.0M.
BlackThorn Therapeutics Employees Turnover 2 quarter 2025
Contact top employees from
BlackThorn Therapeutics
Lucas Slavik
Grants and Contracts Manager
Asish Xavier
Member Board of Directors
Mark Corrigan MD
Chairman Of The Board
John MacPhee
Board of Directors; Compensation Committee
Clark Qingzhu Gao
Senior Data Scientist
Clark Qingzhu Gao
Senior Data Scientist
Company Employee
Managing Director
